Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Small Cell Lung Carcinoma 1Pleural Effusion, Malignant 1Paranasal Sinus Neoplasms 1Nasopharyngeal Carcinoma 1

Interventions

talimogene laherparepvec 1rilotumumab 1lipoplatin 1ganitumab 1cediranib 1Zoledronic Acid 1Verteporfin 1Thoracentesis 1Therapeutics 1Talc 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Spectrum Analysis 1Sodium Chloride 1SPI-77, liposomal 1Radiotherapy, Conformal 1Photochemotherapy 1Nivolumab 1Naproxen 1Immunohistochemistry 1Fluorodeoxyglucose F18 1Fentanyl 1Etoposide 1Drug Therapy 1Doxycycline 1Dihematoporphyrin Ether 1Darbepoetin alfa 1Coal Tar 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Pleural Effusion, Malignant × Coal Tar × Clear all
NCT02132884 2019-09-04

Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

Fox Chase Cancer Center

Phase NA Terminated
1 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡